Meridian Wealth Partners, LLC Abbott Laboratories Transaction History

Meridian Wealth Partners, LLC

$640 Million
Q3 2024

A detailed history of Meridian Wealth Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Meridian Wealth Partners, LLC holds 3,319 shares of ABT stock, worth $380,888. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,319

Previous 3,355 1.07%

Holding current value

$380,888

Previous $348,000 8.62%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $3,602 - $4,252	-36 Reduced 1.07%	3,319 $378,000
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $10,274 - $11,468	102 Added 3.14%	3,355 $348,000
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $17,194 - $18,990	157 Added 5.07%	3,253 $369,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $23,629 - $28,924	262 Added 9.24%	3,096 $340,000
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $18,437 - $22,121	-193 Reduced 6.38%	2,834 $274,000
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $26,001 - $28,970	258 Added 9.32%	3,027 $330,000
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $14,625 - $17,215	-151 Reduced 5.17%	2,769 $280,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $274,628 - $322,181	-2,889 Reduced 49.73%	2,920 $320,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $220,032 - $254,756	-2,274 Reduced 28.13%	5,809 $562,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $42,052 - $50,828	412 Added 5.37%	8,083 $878,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $29,303 - $35,733	257 Added 3.47%	7,671 $908,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $3,581 - $4,385	31 Added 0.42%	7,414 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $4,549 - $5,033	39 Added 0.53%	7,383 $872,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $1,798 - $2,117	-17 Reduced 0.23%	7,344 $851,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $5,659 - $6,667	52 Added 0.71%	7,361 $882,000
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $42,210 - $45,996	-402 Reduced 5.21%	7,309 $801,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $3,573 - $4,340	39 Added 0.51%	7,711 $839,000
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $306 - $392	-4 Reduced 0.05%	7,672 $701,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $1,005 - $1,469	16 Added 0.21%	7,676 $606,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $601,386 - $669,484	7,660 New	7,660 $665,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Partners, LLC with notifications on news.

Account

Meridian Wealth Partners, LLC Abbott Laboratories Transaction History